Ken Griffin
LNAI

Ken Griffin’s Lunai Bioworks LNAI Stock Holding History

Ken Griffin’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,579
Closed -$18.2K – 14019
2025
Q4 		$18.2K Buy
+2,579
New +$23K ﹤0.01% 12362
2025
Q2 		– Sell
-2,076
Closed -$58K – 14651
2025
Q1 		$90.2K Buy
+2,076
New +$133K ﹤0.01% 11611
2024
Q1 		– Sell
-465
Closed -$118K – 15321
2023
Q4 		$118K Buy
465
+155
+50% +$42.5K ﹤0.01% 10724
2023
Q3 		$111K Buy
+310
New +$47.1K ﹤0.01% 10762
2023
Q1 		– Hold
0
– -$1 – 15382
2022
Q4 		– Hold
0
– – – 14812
2022
Q3 		– Sell
-613
Closed -$94K – 13444
2022
Q2 		$94K Sell
613
-108
-15% -$49.4K ﹤0.01% 11473
2022
Q1 		$476K Buy
721
+455
+171% +$242K ﹤0.01% 9505
2021
Q4 		$155K Buy
266
+22
+9% +$16K ﹤0.01% 12212
2021
Q3 		$132K Buy
+244
New +$119K ﹤0.01% 12531
2021
Q2 		– Sell
-470
Closed -$133K – 14294
2021
Q1 		$133K Buy
+470
New +$138K ﹤0.01% 12184

Other funds holding LNAI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $995M AUM 22.79% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ken Griffin's LNAI Position: Q1 2026 in Review

Ken Griffin sold out of Lunai Bioworks (LNAI) in Q1 2026, closing a stake of 2,579 shares — an estimated $18.2K sold.

Ken Griffin first reported a position in LNAI in Q1 2021 and held it in 9 quarters. The position peaked at $476K in Q1 2022. 27 funds tracked by Wall St. Rank hold LNAI as of Q1 2026.

  • Ken Griffin reported no remaining Lunai Bioworks position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 2,579 Lunai Bioworks shares in Q1 2026, an estimated $18.2K.
  • Ken Griffin first reported a position in Lunai Bioworks in Q1 2021 and held it in 9 quarters.
  • Ken Griffin's Lunai Bioworks position peaked at $476K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Lunai Bioworks as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.